PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Excitotoxicity Alters Endogenous Secretoneurin Plasma Levels, but Supplementation with Secretoneurin Does Not Protect Against Excitotoxic Neonatal Brain Injury.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31121260 ↗2019No effect reported

Excitotoxicity Alters Endogenous Secretoneurin Plasma Levels, but Supplementation with Secretoneurin Does Not Protect Against Excitotoxic Neonatal Brain Injury.

MouseTBIUnspecifiedCD-10.25 ug/g body weight, 2.5 ug/g body weight or 12.5 ug/g bo…Single treatment 1 h after insult; acute repetitive treatment starting 1 h afte…

Model: Excitotoxic newborn brain injury induced by intracranial injection of ibotenic acid in mouse pups

Animals subjected to excitotoxic injury had significantly lower secretoneurin plasma concentrations at 6 and 120 h than healthy controls, but secretoneurin supplementation across single, acute repetitive and delayed repetitive regimens did not improve lesion size, apoptotic cell death, microglial a…

Extraction: extract · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.